Headline News

 

Discontinuation Announced by Eisai and Biogen for Phase III Clinical Studies of BACE Inhibitor elenbecestat in Early Alzheimer’s Disease

Posted on September 17, 2019

Agreement in Principle on Landmark Opioid Litigation Settlement Announced by Purdue Pharma

Posted on September 17, 2019

AstraZeneca Annonuces FDA Fast Track Designation for Farxiga in Heart Failure

Posted on September 17, 2019

Lundbeck Announces Agreement to acquire Alder BioPharmaceuticals – in a Transaction Valued at up to USD 1.95 Billion Net of Cash

Posted on September 17, 2019

AstraZeneca will unveil Practice-Changing Data with plans to Redefine at Upcoming Congress

Posted on September 17, 2019

Over-the-Counter, Store-Brand Equivalent of Prevacid® 24HR Capsules Launched by Dr. Reddy’s in the U.S. Market

Posted on September 17, 2019

To Integrate Glucose Sensing and Insulin Delivery Technologies Sanofi and Abbott Partner in bid to Help Change the Way Diabetes is Managed

Posted on September 17, 2019

Orphan Drug Designation Received by Glenmark for GBR 1342, a Bispecific Antibody Candidate Under Evaluation for the Treatment of Multiple Myeloma

Posted on September 17, 2019

New Clinical Data Announced by Amgen Evaluating Novel Investigational KRAS(G12C) Inhibitor In Larger Patient Group At WCLC 2019

Posted on September 10, 2019

AstraZeneca Announce Imfinzi as the First Immunotherapy to Show Both Significant Survival Benefit and Improved, Durable Responses in Extensive-Stage Small Cell Lung Cancer

Posted on September 10, 2019

Positive Results for Selpercatinib (LOXO-292) Announced by Lilly

Posted on September 10, 2019

U.S. FDA Approval for Fosaprepitant for Injection Received by Lupin

Posted on September 10, 2019

U.S. FDA Approval Received by Lupin for Ethacrynic Acid Tablets USP

Posted on September 10, 2019

Zolgensma® Backed by Novartis for the Treatment of Children Less than 2 years of age with Spinal Muscular Atrophy

Posted on September 10, 2019

New OCREVUS (ocrelizumab) Biomarker Data Presented by Roche Increases Understanding of Disease Progression in Multiple Sclerosis at ECTRIMS

Posted on September 10, 2019